Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,697 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease.
Rodríguez-Hernández O, Carrillo-Palau M, Hernández-Camba A, Alonso-Abreu I, Ramos L, de Armas-Rillo L, Martín-González C, López-Mejías R, González-Gay MÁ, Ferraz-Amaro I. Rodríguez-Hernández O, et al. Among authors: ramos l. Int J Mol Sci. 2023 Mar 8;24(6):5194. doi: 10.3390/ijms24065194. Int J Mol Sci. 2023. PMID: 36982268 Free PMC article.
[Internet use among patients with gastrointestinal diseases in a general hospital].
Alarcón-Fernández O, Alonso-Abreu I, Carrillo-Palau M, Nicolás-Pérez D, Gimeno AZ, Ramos L, Guerra de Aguilar MH, Casanova C, Jiménez A, Quintero-Carrión E. Alarcón-Fernández O, et al. Among authors: ramos l. Gastroenterol Hepatol. 2011 Dec;34(10):667-71. doi: 10.1016/j.gastrohep.2011.08.006. Epub 2011 Nov 25. Gastroenterol Hepatol. 2011. PMID: 22119015 Spanish.
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Guerra I, Pérez-Jeldres T, Iborra M, Algaba A, Monfort D, Calvet X, Chaparro M, Mañosa M, Hinojosa E, Minguez M, Ortiz de Zarate J, Márquez L, Prieto V, García-Sánchez V, Guardiola J, Rodriguez GE, Martín-Arranz MD, García-Tercero I, Sicilia B, Masedo Á, Lorente R, Rivero M, Fernández-Salazar L, Gutiérrez A, Van Domselaar M, López-SanRomán A, Ber Y, García-Sepulcre M, Ramos L, Bermejo F, Gisbert JP; Spanish GETECCU group (ENEIDA project). Guerra I, et al. Among authors: ramos l. Inflamm Bowel Dis. 2016 Apr;22(4):894-901. doi: 10.1097/MIB.0000000000000757. Inflamm Bowel Dis. 2016. PMID: 26933750 Free article.
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Casanova MJ, Chaparro M, García-Sánchez V, Nantes O, Leo E, Rojas-Feria M, Jauregui-Amezaga A, García-López S, Huguet JM, Arguelles-Arias F, Aicart M, Marín-Jiménez I, Gómez-García M, Muñoz F, Esteve M, Bujanda L, Cortés X, Tosca J, Pineda JR, Mañosa M, Llaó J, Guardiola J, Pérez-Martínez I, Muñoz C, González-Lama Y, Hinojosa J, Vázquez JM, Martinez-Montiel MP, Rodríguez GE, Pajares R, García-Sepulcre MF, Hernández-Martínez A, Pérez-Calle JL, Beltrán B, Busquets D, Ramos L, Bermejo F, Barrio J, Barreiro-de Acosta M, Roncedo O, Calvet X, Hervías D, Gomollón F, Domínguez-Antonaya M, Alcaín G, Sicilia B, Dueñas C, Gutiérrez A, Lorente-Poyatos R, Domínguez M, Khorrami S, Muñoz C, Taxonera C, Rodríguez-Pérez A, Ponferrada A, Van Domselaar M, Arias-Rivera ML, Merino O, Castro E, Marrero JM, Martín-Arranz M, Botella B, Fernández-Salazar L, Monfort D, Opio V, García-Herola A, Menacho M, Ramírez-de la Piscina P, Ceballos D, Almela P, Navarro-Llavat M, Robles-Alonso V, Vega-López AB, Moraleja I, Novella MT, Castaño-Milla C, Sánchez-Torres A, Benítez JM, Rodríguez C, Castro L, Garrido E, Domènech E, García-Planella E, Gisbert JP. Casanova MJ, et al. Among authors: ramos l. Am J Gastroenterol. 2017 Jan;112(1):120-131. doi: 10.1038/ajg.2016.569. Epub 2016 Dec 13. Am J Gastroenterol. 2017. PMID: 27958281 Free article.
Predictive factors of clinical response to treatment with anti-TNF agents in ulcerative colitis: what have we learned from our patients?
Ramos L, Hernández Camba A, de la Barreda Heusser R, Vela M, Alonso-Abreu I, Rodríguez G E, Carrillo M, Tardillo C, Rodríguez Y, Figueroa Marrero A, Ceballos D, Cruz N, Kolle-Casso L, Jiménez Sosa A. Ramos L, et al. Rev Esp Enferm Dig. 2020 Aug;112(8):636-641. doi: 10.17235/reed.2020.6688/2019. Rev Esp Enferm Dig. 2020. PMID: 32579006 Free article.
Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk.
Hernández-Camba A, Carrillo-Palau M, Ramos L, Hernández Alvarez-Buylla N, Alonso-Abreu I, Hernández-Pérez A, Vela M, Arranz L, Hernández-Guerra M, González-Gay MÁ, Ferraz-Amaro I. Hernández-Camba A, et al. Among authors: ramos l. J Clin Med. 2021 Apr 13;10(8):1671. doi: 10.3390/jcm10081671. J Clin Med. 2021. PMID: 33924727 Free PMC article.
Adherence to subcutaneous biologic treatment for inflammatory bowel disease.
Ramos L, Ramos-Rodríguez J, Barreda R, Gutiérrez-Nicolás F, Carrillo-Palau M, Alonso-Abreu I, Nazco-Casariego J, Quintero E. Ramos L, et al. Among authors: ramos rodriguez j. Gastroenterol Hepatol. 2022 May;45(5):335-341. doi: 10.1016/j.gastrohep.2021.04.011. Epub 2021 May 27. Gastroenterol Hepatol. 2022. PMID: 34051312 English, Spanish.
1,697 results